Immunome, Inc. (IMNM) has a market capitalization of $2.01B and trades at $22.90. The 52-week range is 5.15-27.65.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -9.4, Earnings Per Share (EPS) of $-2.43, annual revenue of $6.94M.
The stock has a beta of 2.14, operates in the Healthcare sector.
